{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

University of Toronto

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

- economic aspects of the pharmaceutical industry, including drug development; pharmaceuticals use, insurance and reimbursement; and interactions between innovative (brand) and generic drug firms. - methods for program evaluation using observational data.

Brief Bio:

Paul Grootendorst examines economics issues in the pharmaceutical sector, with a particular focus on drug pricing, insurance and the provision of community pharmacy services. His work helps to inform public policy related to pricing, reimbursement and coverage.

{!{types field=’prefix’ separator=’, ‘}!}{!{/types}!} {!{types field=’first-name’}!}{!{/types}!} {!{types field=’last-name’}!}{!{/types}!}

{!{types field=’degrees-or-credentials’ separator=’, ‘}!}{!{/types}!}

University of Toronto

{!{types field=’position’ separator=’, ‘}!}{!{/types}!}

Research Interests:

- economic aspects of the pharmaceutical industry, including drug development; pharmaceuticals use, insurance and reimbursement; and interactions between innovative (brand) and generic drug firms. - methods for program evaluation using observational data.

Brief Bio:

Paul Grootendorst examines economics issues in the pharmaceutical sector, with a particular focus on drug pricing, insurance and the provision of community pharmacy services. His work helps to inform public policy related to pricing, reimbursement and coverage.